Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 352 participants.

Also called NCT07475949

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 352 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07475949
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07475949. Randomized; single masking; primary purpose treatment. Start 2026-09-24 (actual); primary completion 2028-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Unknown Time of Onset Stroke RePerfusIon Without Advanced Imaging
Acronym
UTOPIA
Condition
Acute Ischemic Stroke
Condition
Tenecteplase
Intervention (Drug)
Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg)
Intervention (Other)
Standard medical treatment
Lead sponsor
First Affiliated Hospital of Guangxi Medical University (class: other)

Record details

Record id
cardio:ct-nct07475949
Content hash
aef56f5b798e0a61d58760d91d0d64b0efc957376479a27e08a7fec298ac6ef7